Ankylosing spondylitis: Understanding disease progression to better plan for the future
Published 6 Jun 2026 • By Candice Salomé
Receiving a diagnosis of ankylosing spondylitis often raises one key question: how will the disease progress over time?
Between uncertainty, worries about the future, and the need to make plans, it can be difficult to find clear answers. Yet understanding the mechanisms behind the disease and the different ways it may evolve can help bring a greater sense of perspective and control.
Although ankylosing spondylitis is not entirely predictable, advances in medical care have significantly improved its management in recent years. As a result, the outlook for many people living with the condition is changing, along with the way this chronic disease is perceived.
An evolving disease… but not a linear one: Understanding the possible trajectories
A highly variable course from one person to another
Ankylosing spondylitis is a chronic inflammatory disease that does not follow a single path. For some people, symptoms remain relatively mild and progress slowly, while others may experience more significant disease progression.
This variability is partly explained by genetic factors, such as the presence of the HLA-B27 gene, but also by environmental influences and how quickly the condition is diagnosed. The disease typically progresses in phases, with periods of inflammatory flare-ups alternating with periods of relative calm.
The different stages the disease may go through
The disease often begins with inflammatory lower back pain that develops gradually and tends to worsen at night or during periods of rest. Over time, inflammation may spread to other areas, including the spine, peripheral joints, or the sites where tendons attach to bone (entheses).
In some cases, structural changes can occur, leading to progressive stiffening of the spine, known as ankylosis. However, not everyone with ankylosing spondylitis develops these more advanced forms of the disease.
What current research tells us
Long-term studies show that structural progression can be slow and highly variable. Advances in imaging have improved the ability to detect early changes and monitor how the disease evolves over time.
In addition, the introduction of biologic therapies has significantly improved the outlook for many patients by reducing inflammation and helping limit long-term damage.
Living with a chronic disease: Between uncertainty and adaptation
An impact that changes over time
Beyond its physical effects, ankylosing spondylitis can have a broad impact on quality of life. Pain, fatigue, and stiffness may fluctuate over days, months, and years.
These changes can affect work, social relationships, and everyday activities. The uncertainty surrounding the disease's progression can also weigh heavily on emotional well-being and make it more difficult to plan for the future.
Gradually adapting to everyday life
Over time, many people develop strategies to adapt. They learn to recognise their body's signals, adjust their pace, and manage periods of fatigue or pain.
This adaptation does not mean giving up. Rather, it often involves redefining balance and finding new ways to navigate daily life. It is usually a gradual process marked by ongoing adjustments.
A changing relationship with the disease
The way people view their condition often evolves over time. After the initial shock of diagnosis, some describe a gradual process of acceptance.
This psychological adjustment can help people integrate the disease into their daily lives and rebuild a sense of stability, even when symptoms persist.
Looking ahead more confidently: Knowledge, monitoring, and hope
The role of ongoing monitoring in long-term planning
Regular medical follow-up helps track the disease over time and allows treatment plans to be adjusted as needed. It forms part of a long-term care journey that supports patients throughout the course of the disease.
Ongoing monitoring can also help people better understand their own condition and make future plans based on more concrete information.
Medical advances are changing the outlook
In recent years, therapeutic advances have transformed the management of ankylosing spondylitis. Biologic therapies, particularly TNF inhibitors and IL-17 inhibitors, have made it possible to control inflammation more effectively.
These advances are helping improve quality of life and reduce the risk of structural progression for many patients, reshaping long-term expectations.
Looking at the future differently with a chronic illness
Planning for the future with a chronic disease does not necessarily mean expecting things to get worse. It can also mean rethinking goals, adapting plans, and building a future that is compatible with your abilities and priorities.
Many people living with ankylosing spondylitis describe finding new ways to define success, adjust their expectations, and create a fulfilling life despite uncertainty.
FAQ: Ankylosing spondylitis and disease progression
Does ankylosing spondylitis always progress to a severe form?
No. Disease progression varies greatly from person to person. Some individuals experience relatively mild disease, while others may develop more significant complications.
Can the course of the disease be predicted?
It is difficult to predict exactly how ankylosing spondylitis will evolve in an individual. Certain factors may help indicate a possible prognosis, but there are no guarantees.
Do current treatments change how the disease progresses?
Modern treatments, particularly biologic therapies, can help control inflammation more effectively and may slow disease progression in some people.
Does ankylosing spondylitis always affect mobility?
Not necessarily. The impact on mobility varies depending on the individual and how the disease evolves over time.
How can you plan for the future with an unpredictable disease?
Planning for the future often becomes easier with a better understanding of the condition, appropriate medical follow-up, and the flexibility to adapt goals and expectations over time.
Did you find this article helpful?
Click "Like" or share your thoughts, experiences, and questions with the community in the comments below!
Take care!
Sources :
Lee TH, Koo BS, Nam B, Kim YJ, Son D, Lee S, Joo KB, Kim TH. Age-stratified trends in the progression of spinal radiographic damage in patients with ankylosing spondylitis: a longitudinal study. Ther Adv Musculoskelet Dis. 2022 May 23;14:1759720X221100301. doi: 10.1177/1759720X221100301. PMID: 35634353; PMCID: PMC9131377.
Maas F, Arends S, Wink FR, Bos R, Bootsma H, Brouwer E, Spoorenberg A. Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors. PLoS One. 2017 Jun 22;12(6):e0177231. doi: 10.1371/journal.pone.0177231. PMID: 28640818; PMCID: PMC5480831.